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From the Editor’s Desk: 
Frontiers in medicine: the McGill Journal of
Medicine celebrates ten years, and insights into
interventional medicine 
This issue of the McGill Journal of Medicine marks
something of an anniversary for the Journal, and before
commenting on the articles in this issue, we thought
this a fitting time for reflection on the state of the MJM.
Though we chart our recent history through a period of
beginning, ending, and beginning and ending again, we
have embarked with conviction on the course which
was once set for the Journal. The involvement of
students from around the world during the past ten
years – we estimate the participation of over five
hundred students in the MJM since its re-establishment
in the 1990s – has made this international effort
possible. The MJM provides exposure for young
aspiring clinicians and scientists to medical science –
something that we feel is insufficiently invited by many
medical school curricula. The experience is valuable to
both our staff of over 120 current editors from around
the world, and to those reading and submitting articles
to the Journal. Additionally, though, we believe that the
Journal empowers people in traditionally under-
represented areas. We are proud to feature, for
example, in this issue an article from students in North
Carolina, U.S., on dentition in Costa Rica. Garcia and
Guzzo provide excellent insight into the strengths and
weaknesses of the oral hygiene programs in selected
communities throughout Costa Rica, as influenced by
allocation of dentists and the construction on the Inter-
American Highway. Their work represents proficient
medical research, with important implications for
public health in developing countries. The staff at the
MJM hope that we will open a dialogue between young
people interested in bettering health in countries that
have traditionally not had the representation in medical
science and public health literature that North America,
Europe, and parts of Asia have enjoyed. The Journal in
this respect is a forum for young, ambitious people to
meet, to brainstorm medical challenges by discoursing
and sharing insights, and to solve problems throughout
the world.
Impetus for this perspective is exemplified by a
recent research project of one of the Editors-in-Chief of
this issue, who had the opportunity to work with a
group studying leishmaniasis in Peru. Leishmaniasis is
a parasitic infection that manifests as either cutaneous,
muco-cutaneous (which can develop as a sequelae to
the cutaneous form), or visceral disease. The parasite is
transmitted by the sandfly, which feeds on humans or
dogs (the reservoir for the disease), in a manner
reminiscent to malaria. The disease is common among
people living in endemic regions of Peru, Brazil,
Bolivia, and much of Africa and the Middle East.
Presently, medical treatment consists of a 20-day
course of pentavalent antimoy injections, which is not
always successful, and often results in deforming scars
(particularly when the disease is contracted on the face,
where more farmers work without protection). Non-
medical treatment, employed by the local people,
consists of drinking a tintiucre referred to locally as
"sangre del arbol" – a tree extract – and additionally by
applying battery acid to the superficial lesion.
Our group has been working on developing a topical
approach to disease management. We are testing a
topical cream, imiquimod, which has been approved by
the American F.D.A. for use in treating HPV cutaneous
warts. Imiquimod is a toll-like receptor (TLR) agonist,
activating fixed tissue macrophages which engulfed the
parasite in the tissue as part of the innate host defense
process. Once activated in this site-specific manner, the
macrophages fuse the phagosome (the intracellular
compartment containing the parasite) with lysosomes
(the macrophage’s acidic compartments that digest
debris and foreign particles). We hope that these studies
will become part of a cadre of evidence from this lab
that supports a shift away from the archaic antimony
treatment to a more topical, and less offending
treatment of this infection. The premise of the work is,
simply put, empowering people in the countries with
need. The problem originated in Peru, but the tools
used to address it (used, furthermore, by the team of
local doctors helping in the study), comes from our
end. We hope to recapitulate collaborations like these
among young people in expanding the McGill Journal
of Medicine. 
In addition to the Costa Rica study herein, we are
pleased to feature a Focus on “interventional
medicine.” The future of medical science rests heavily
on the decisions of the rising generation. As such, we
have expanded the Focus section in recent years,
inviting reviews from experts in developing fields of
medicine, and hopefully inviting discussion among
readers about these new topics. In this issue, we feature
four expert reviews on interventional medicine, which
uses minimally invasive procedures to effect medical
outcomes. These articles are eloquently written, and are
an excellent amalgam of insights into the diverse
applications of interventional medicine. Additionally,
we have also chosen an article from a group at the
University of Manitoba that studied “door-to-balloon”
times at the authors’ hospital in Winnipeg. Primary
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percutaneous coronary intervention is preferable for
patients in whom the first medical contact (the “door-
to-balloon” interval) has occurred within 90 minutes.
Additionally, it is preferred to conventional fibrinolysis
in certain patients even if the interval between the first
medical contact and the procedure exceeds 90 minutes
(namely, patients with fibrinolysis contraindications,
patients over 75, and patients in cardiogenic shock).  As
such, establishing the efficiency of putting patients’
vessels in the hands of an intervntionalist become of
the utmost importance. Only with analysis like the
Manatoba study herein will efficiency be improved and
lives saved. 
Finally, this issue of the MJM also features a special
Abstract Section wherein abstracts presented at the 2nd
Annual Conference of the Canadian Society for Life
Science Research (CSLSR) are published. The CSLSR
is a non-profit organization created by life science
students that is dedicated to bringing together young
Canadian researchers at all university levels to share
their knowledge, research, and discoveries. This year’s
CSLSR conference was held at McGill University and
brought together students from across the country. The
MJM is a proud supporter of this wonderful student
initiative. The CSLSR and MJM will continue to
support young researchers in their endeavors. It is our
hope that students in life science from Canada and
across the world will continue to involve themselves in
such student forums in order to further their knowledge
and encourage each other’s work in research.
We hope you enjoy these abstracts as well as the
other articles herein. We invite you to consider
becoming a part of the MJM team: as a contributor,
editor, or reader. Our door is always open. 
PRL, WM, PW
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